Trial · NCT00345800
Registered outcomes36
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 20 of 36
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | The Insulin-like Growth Factor 1 (IGF-1) Measured in Fasting Conditions at Baseline (Visit 2) | Baseline (Visit 2) - approximately 1 day | An assay of IGF-1 was done from blood sampled about 10 hours after bedtime on Visit 2. |
| Primary | The Insulin-like Growth Factor 1 (IGF-1) Measured in Fasting Conditions After 1 Month of Treatment (Visit 3) | After 1 month of treatment (Visit 3) | An assay of IGF-1 was done from blood sampled about 10 hours postdose on Visit 3. |
| Primary | The Insulin-like Growth Factor 1 (IGF-1) Measured in Fasting Conditions After 3 Months of Treatment (Visit 4) | After 3 months of treatment (Visit 4) | An assay of IGF-1 was done from blood sampled about 10 hours postdose on Visit 4. |
| Secondary | The Circadian Rhythm of the Growth Hormone (GH) Measured at Baseline (Visit 2) | Baseline (Visit 2) - approximately 1 day | Blood was sampled at Baseline (Visit 2) at bedtime 10:00 pm and 1, 2, 4, 8, 12, 16, and 20 hours after bedtime for assaying GH. |
| Secondary | The Circadian Rhythm of the Growth Hormone (GH) Measured at Visit 3 | Visit 3 (approximately 1 month) | Blood was sampled predose and 1, 2, 4, 8, 12, 16, and 20 hours postdose at Visit 3 for assaying GH. |
| Secondary | The Circadian Rhythm of the Growth Hormone (GH) Measured at Visit 4 | Visit 4 (approximately 3 months) | Blood was sampled predose and 1, 2, 4, 8, 12, 16, and 20 hours postdose at Visit 4 for assaying GH. |
| Secondary | Cortisol Measured at Baseline (Visit 2) | Baseline (Visit 2) - approximately 1 day | Blood was sampled at Baseline (Visit 2) at bedtime 10:00 pm and 1, 2, 4, 8, 12, 16, and 20 hours after bedtime for assaying cortisol. |
| Secondary | Cortisol Measured at Visit 3 | Visit 3 (approximately 1 month) | Blood was sampled predose and and 1, 2, 4, 8, 12, 16, and 20 hours postdose at Visit 3 for assaying cortisol. |
| Secondary | Cortisol Measured at Visit 4 | Visit 4 (approximately 3 months) | Blood was sampled predose and 1, 2, 4, 8, 12, 16, and 20 hours postdose at Visit 4 for assaying cortisol. |
| Secondary | The Adrenocorticotropic Hormone (ACTH) Measured in Fasting Conditions at Baseline (Visit 2) | Baseline (Visit 2) - approximately 1 day | An assay of ACTH was done from blood sampled about 10 hours after bedtime on Visit 2. |
| Secondary | The Adrenocorticotropic Hormone (ACTH) Measured in Fasting Conditions at Visit 3 | Visit 3 (approximately 1 month) | An assay of ACTH was done from blood sampled about 10 hours postdose on Visit 3. |
| Secondary | The Adrenocorticotropic Hormone (ACTH) Measured in Fasting Conditions at Visit 4 | Visit 4 (approximately 3 months) | An assay of ACTH was done from blood sampled about 10 hours postdose on Visit 4. |
| Secondary | The Dehydroepiandrosterone Sulfate (DHEA-S) Measured in Fasting Conditions at Baseline (Visit 2) | Baseline (Visit 2) - approximately 1 day | An assay of DHEA-S was done from blood sampled about 10 hours after bedtime on Visit 2. |
| Secondary | The Dehydroepiandrosterone Sulfate (DHEA-S) Measured in Fasting Conditions at Visit 3 | Visit 3 (approximately 1 month) | An assay of DHEA-S was done from blood sampled about 10 hours postdose on Visit 3. |
| Secondary | The Dehydroepiandrosterone Sulfate (DHEA-S) Measured in Fasting Conditions at Visit 4 | Visit 4 (approximately 3 months) | An assay of DHEA-S was done from blood sampled about 10 hours postdose on Visit 4. |
| Secondary | The Prolactin Measured in Fasting Conditions at Baseline (Visit 2) | Baseline (Visit 2) - approximately 1 day | An assay of prolactin was done from blood sampled about 10 hours after bedtime on Visit 2. |
| Secondary | The Prolactin Measured in Fasting Conditions at Visit 3 | Visit 3 (approximately 1 month) | An assay of prolactin was done from blood sampled about 10 hours postdose on Visit 3. |
| Secondary | The Prolactin Measured in Fasting Conditions at Visit 4 | Visit 4 (approximately 3 months) | An assay of prolactin was done from blood sampled about 10 hours postdose on Visit 4. |
| Secondary | The Thyroid Stimulating Hormone (TSH) Measured in Fasting Conditions at Baseline (Visit 2) | Baseline (Visit 2) - approximately 1 day | An assay of TSH was done from blood sampled about 10 hours after bedtime on Visit 2. |
| Secondary | The Thyroid Stimulating Hormone (TSH) Measured in Fasting Conditions at Visit 3 | Visit 3 (approximately 1 month) | An assay of TSH was done from blood sampled about 10 hours postdose on Visit 3. |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00345800/registered